Indianapolis sits at the center of Indiana's pharmaceutical, insurance, and agricultural technology sectors, all of which generate securities compliance requirements ranging from private placements to regulatory filings tied to M&A transactions. Whether you are structuring a Reg D offering for a biotech startup, handling securities compliance in an insurance company acquisition, or advising an ag-tech company on investor documentation, the work requires counsel who understands both federal securities law and Indiana's specific regulatory framework. Our managing partner handles securities engagements directly.
Share the basics. Alex reviews each inquiry personally.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Alex Lubyansky handles securities law work for buyers and sellers in Indianapolis and across the country. Here is what that looks like:
We work best with people who know what they want and are ready to move:
Share the relevant deal details once. Alex reviews each inquiry personally and responds within one business day when there is alignment.
A structured, methodical approach to securities law
We discuss your securities law needs, review your current situation, and outline potential strategies and timelines.
Our team conducts thorough due diligence of your corporate structure, financial statements, and compliance history.
We develop a customized securities strategy tailored to your business goals, whether it's going public, raising capital, or maintaining compliance.
We prepare and file all necessary documentation with the SEC, state regulators, and exchanges, managing the entire process.
After the transaction closes, we provide continued support for ongoing compliance, reporting, and corporate governance matters.
We don't take every matter. Here is what happens when you reach out.
Alex reviews your transaction details personally. Your submission is not screened by an intake coordinator before it reaches him.
We evaluate whether your deal aligns with our practice. Not every matter is a fit, and we will tell you directly if it is not.
If there is alignment, Alex schedules a direct call to discuss your transaction, timeline, and objectives.
Before any work begins, you receive a written engagement letter with defined scope, timeline, and fee structure. No surprises.
Alex Lubyansky handles every securities law engagement personally.
15+ years of M&A experience. Nationwide. LOI through closing.
Alex reviews each inquiry personally. If there is alignment, you will hear back within one business day.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Common questions from Indianapolis clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsSubmit the core transaction details and Alex will evaluate whether the matter is a fit for direct engagement.
Indianapolis is a major center for life sciences and pharmaceutical M&A, anchored by Eli Lilly's massive presence and a network of contract research organizations, medical device companies, and health tech startups. The city's logistics sector, fueled by its position as the 'Crossroads of America' with more interstate highways than any other U.S. city, generates significant deal activity in trucking, warehousing, and supply chain services. Motorsports engineering and agribusiness round out a distinctive mid-market M&A landscape.
Indianapolis offers robust deal flow in the $2M-$25M range, with many family-owned logistics and manufacturing businesses approaching generational transitions. The market is moderately competitive, with local firms like Hammond Kennedy Whitney and Centerfield Capital competing for quality deals alongside national PE platforms building Midwest portfolios.
Indiana's pro-business tax environment, including no tax on inventory for manufacturers and distributors, makes Indianapolis acquisitions financially attractive from day one. The metro's central location enables next-day ground shipping to 75% of the U.S. population, a compelling logistics advantage for distribution-oriented roll-ups.
Indiana has adopted the Revised Uniform Limited Liability Company Act with business-friendly provisions, and the state's non-compete law was updated in 2016 to require employers to provide independent consideration for existing employees, which directly affects workforce retention assumptions in acquisition models.
Indianapolis is home to Eli Lilly and a broader pharmaceutical and life sciences cluster that extends through the Meridian Corridor and the Indiana University research ecosystem. This concentration produces securities work tied to capital raises for biotech startups, licensing transactions with securities components, and M&A deals involving regulated entities. The insurance industry is another defining feature of the Indianapolis market. Several major carriers and managing general agents are headquartered here, and transactions involving insurance entities trigger state regulatory approvals and securities compliance obligations. Indiana's growing ag-tech sector, fueled by the state's agricultural base and Purdue University's research programs, generates venture-stage capital raises and acquisition activity. Motor sports and the Indianapolis Motor Speedway ecosystem also support a niche of sponsorship, licensing, and entertainment ventures that occasionally involve securities structuring.
Indianapolis-area biotech and pharmaceutical companies frequently raise capital through Regulation D private placements (Rule 506(b) or 506(c)). The legal work involves preparing the private placement memorandum, subscription agreements, and operating agreement amendments. Accredited investor verification is required for 506(c) offerings. Indiana's Blue Sky filing requirements must be satisfied through Form D filing and any applicable state notice filings. For life sciences companies, the offering documents must accurately disclose regulatory risks, IP ownership, and clinical trial status.
Acquiring or investing in an Indiana-domiciled insurance company involves securities compliance layered on top of state insurance regulatory requirements. The Indiana Department of Insurance must approve changes of control, and the transaction may also trigger SEC filing requirements depending on the structure. Hart-Scott-Rodino filing thresholds, Form A filings with the insurance department, and securities law exemption analysis for the transaction structure are all part of the legal work.
Indiana's agricultural technology companies, from precision agriculture to crop science startups, raise capital from a mix of traditional venture firms and strategic agricultural investors. The securities work involves structuring the investment (preferred equity, convertible notes, SAFEs), preparing investor documentation that complies with Reg D, and navigating the specific disclosure requirements for companies with IP tied to university research or USDA grants. Anti-dilution provisions and liquidation preferences are key negotiation points.
Indianapolis combines a pharmaceutical and life sciences cluster, a concentrated insurance industry, and a growing agricultural technology sector. Each of these verticals generates securities compliance work that requires understanding of both federal regulations and Indiana's state-level requirements. The city's cost structure is significantly lower than coastal financial centers, but the complexity of the securities work is comparable. Companies raising capital, executing M&A transactions involving regulated entities, or structuring investor arrangements need counsel who can navigate the intersection of securities law, industry-specific regulation, and Indiana's regulatory framework.
Enforceable with blue-pencil modification. Physician non-competes restricted.
Entity mergers and conversions require filing with the Indiana Secretary of State, Business Services Division. Annual business entity reports are required. Regulated industry acquisitions (gaming, utilities, insurance) require separate agency approvals.
Indiana State Bar Association. Voluntary bar. Indiana Supreme Court handles attorney admission separately.
Bar association websiteFederal districts: N.D. Ind., S.D. Ind.
Business court: Indiana Commercial Court (established 2016) Indiana Supreme Court established a pilot commercial court program; business courts operate in Marion County (Indianapolis) and other counties. Source: Indiana Commercial Court
Indiana M&A clusters around Indianapolis in life sciences and healthcare services, with secondary deal flow in manufacturing and logistics sectors.
Watchpoints
These are the items we see derail securities law transactions in the Indianapolis market. Each one is rooted in current statutory law, recent legislative changes, or recurring patterns from the deals Alex has handled.
Expanded the prohibition on non-compete agreements between hospitals and physicians. Hospitals are now prohibited from using noncompetes, nonsolicits longer than one year, and no-service agreements with their physicians, and there are limitations on training repayment agreements.
SourceEnforceable with blue-pencil modification. Physician non-competes restricted.
"Founders get excited about the check amount and focus on valuation headlines while the fine print gets glossed over."
Securities regulated by Indiana Secretary of State Securities Division (in.gov/sos/securities). Indiana follows the Uniform Securities Act; Blue Sky notice filings required for Reg D.
In-depth guides to help you prepare for your transaction
Full-service M&A counsel from letter of intent through closing.
Read guideA structured approach to legal, financial, and operational due diligence.
Read guideUnderstanding the binding and non-binding elements of each document.
Read guideCommon deal-killers and how experienced counsel helps prevent them.
Read guideAcquisition Stars represents clients across Indiana and nationwide. Alex Lubyansky leads every engagement.
Don't see your city? View all Securities Lawyer service areas or contact us directly.
"For companies issuing new shares now, the structure and timing of new issuances matters more than ever."
15+ years of M&A and securities transaction experience Senior counsel on every engagement Admitted in Michigan, practicing nationwide
Reviewed by Alex Lubyansky on . Read full bio
Alex Lubyansky handles every engagement personally. Tell us about your transaction and we will let you know if there is a fit.
LOI through closing. Nationwide. 15+ years of M&A experience.